Illustration(s) pertain to the topic addressed in this publication, not the specific research or data presented in the publication

Who We Are / Areas of Expertise

Janine Jason, M.D.

Pediatrics, Board-certified
Immunology/Allergy, Board-eligible

Clinical and Research Expertise in Infectious Diseases
Trained in the Epidemiology Intelligence Service (EIS) Program, Centers for Disease Control & Prevention

Dr. Jason has over 35 years of research experience, clinical expertise and numerous peer-reviewed publications, including the areas of:

Epidemiology: medical cost analyses, disease incidence and prevalence estimations, medical cost-benefit calculations; design, analysis, and interpretation of epidemiologic studies, data, and outbreaks; infectious disease epidemiology; and epidemiologic techniques
Pediatrics: child health, infant feeding, breast feeding, infant mortality, child abuse, child homicide, parenting, and caring for premature infants
Infectious diseases: HIV/AIDS, hepatitis B (HBV), hepatitis C (HCV), herpes viruses including herpes simplex virus (HSV), hemophilia-associated AIDS, blood product-related infections, blood product safety, medical device-associated infections, bloodborne pathogens, accidental needlestick injuries, and pediatric infections
Therapy of infectious diseases: reviewing clinical research articles and educating investors and corporate executives about the associated findings, including those related to hepatitis C (HCV), human immunodeficiency virus (HIV) infections and treatment, and immunotherapies
Immunology: immunodeficiency, opportunistic infections, cytokines, T-cell immunology, immunologic laboratory techniques, immunotherapies, and flow cytometry
Public Health: HIV, health communications, parenting, and assessments of the incidence, prevalence, and healthcare costs associated with various diseases
Translating basic research: reviewing and interpreting basic immunologic and microbiologic research articles and educating investors and corporate executives about the practical implcations of the associated findings
Medical legal expert consulting: on select cases only
Recent research topics:¬†Dr. Jason’s recent projects have included determining the incidence, characteristics, and associated healthcare costs of community-acquired accidental needlestick injuries, evaluating the risks of¬†transmission of bloodborne pathogens (including HIV, HBV, and HCV) in health care, occupational, and community settings, and advising State legislators of her findings; epidemiologic studies of Cronobacter sakazakii (formerly Enterobacter sakazakii) infections in children; and determining the incidence, characteristics, and associated healthcare costs of polycystic ovary syndrome (PCOS). ¬†Dr. Jason has recently authored peer-reviewed papers on these topics. She has also assisted in medical outbreaks and legal cases involving various: infections, including HIV, HCV, herpes viruses (including HSV), coxsackie viruses, cytomegalovirus, Salmonella, Legionella, toxoplasmosis, tubercular and no-tubercular mycobacteria, Streptococcus, and methicillin-sensitive and resistant Staphylococcus aureus (MSSA and MRSA); syndromes, including toxic shock syndrome, necrotizing fasciitis, and Kawasaki disease; infectious disease complications related to drug therapies, transplantation, and immunodeficiency disorders.

williamjarvisWilliam R. Jarvis, M.D.

Pediatrics, Board-certified
Pediatric Infectious Diseases, Board-eligible

Dr. Jarvis has over 40 years of clinical expertise and over 400 peer-reviewed publications concerning:

  • infection control,
  • healthcare epidemiology,
  • outbreak investigations,
  • pediatric infectious diseases,
  • infectious diseases,
  • surgical site infections,
  • bloodstream infections,
  • pneumonia,
  • urinary tract infections,
  • all device -associated infections,
  • cost-benefit of infection control,
  • antimicrobial resistance (particularly methicillin-resistant Staphylococcus aureus [MRSA] and vancomycin-resistant enterococci [VRE] or S. aureus [including VISA or VRSA]),
  • prevention and control of Mycobacterium tuberculosis transmission to patients and healthcare workers [national and international],
  • infection control in developing countries,
  • guidelines for prevention and control of infections in healthcare settings,
  • patient safety,
  • healthcare-associated infection surveillance,
  • fungal infections,
  • adverse events associated with healthcare delivery,
  • and epidemiologic methods.